News | May 23, 2025
Venus Remedies secures Ukrainian GMP renewal
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
Certification bolsters Venus Remedies' position in PIC/S markets, reinforcing commitment to global quality standards
The inspection conducted from December 16, 2024 to December 20, 2024 by the Brazil Health Regulatory Agency (ANVISA)
The capital raise will also support debt repayment or prepayment, improving the company's debt-to-equity ratio and overall financial resilience
Blenrep combinations could redefine treatment as early as first relapse where more effective options are needed
The portfolio includes branded injectable cephalosporines for infectious diseases
The first-of-its-kind study will evaluate potential association between GSK’s shingles vaccine and reduced dementia risk, building on growing body of evidence from observational and retrospective studies
The freshly infused capital will primarily be deployed towards expansion and research & development
Prior to joining Neuland, Deshmukh held several key positions at Cipla
PCC has secured the commercialization rights for the EU, UK, and Norway and will be responsible for distributing Neoatricon in these regions
Talicia is also approved and launched in the UAE and additional countries may accept UK MHRA approvals as a reference for their own marketing approval processes
Subscribe To Our Newsletter & Stay Updated
